We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTime to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.AuthorsGuglielmi, C; Gomez, F; Philip, T; Hagenbeek, A; Martelli, M; Sebban, C; Milpied, N; Bron, D; Cahn, J Y; Somers, R; Sonneveld, P; Gisselbrecht, C; Van Der Lelie, H; Chauvin, FPublicationJournal of Clinical Oncology, 1998, Vol 16, Issue 10, p3264ISSN0732-183xPublication typearticleDOI10.1200/jco.1998.16.10.3264